The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice

Wang, Peng-Hui; Yang, Szu-Ting; Liu, Chia-Hao

doi:10.1016/j.tjog.2024.05.004

Taiwanese Journal of Obstetrics and Gynecology

2024

DOI: 10.1016/j.tjog.2024.05.004

|View full text |Cite

The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice

Peng-Hui Wang,

Szu-Ting Yang,

Chia-Hao Liu

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Besides the front-line maintenance therapy, is any positive impact of poly (ADP-ribose) polymerase (PARP) inhibitors on recurrent high-grade ovarian cancer?

Li,

Wang

2024

Taiwanese Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

Besides the front-line maintenance therapy, is any positive impact of poly (ADP-ribose) polymerase (PARP) inhibitors on recurrent high-grade ovarian cancer?

Li,

Wang

2024

Taiwanese Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer

Chang,

Yang,

Liu

et al. 2024

Taiwanese Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

Antibody–drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (II): Anti-HER2/neu

Wang,

Chao,

Lee

2024

Taiwanese Journal of Obstetrics and Gynecology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice

Cited by 3 publications

References 20 publications

Besides the front-line maintenance therapy, is any positive impact of poly (ADP-ribose) polymerase (PARP) inhibitors on recurrent high-grade ovarian cancer?

Besides the front-line maintenance therapy, is any positive impact of poly (ADP-ribose) polymerase (PARP) inhibitors on recurrent high-grade ovarian cancer?

Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer

Antibody–drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (II): Anti-HER2/neu

Contact Info

Product

Resources

About